Clinical Trials Directory

Trials / Unknown

UnknownNCT03944083

Children With ADHD and Emotional Dysregulation

Emotional Dysregulation in Children With Attention Deficit Hyperactivity Disorder (ADHD)

Status
Unknown
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Oslo University Hospital · Academic / Other
Sex
All
Age
6 Years – 12 Years
Healthy volunteers
Not accepted

Summary

Studies have shown that children with Attention Deficit Hyperactivity Disorder (ADHD) and emotional dysregulation are characterized by high severity of ADHD, comorbid behavior disorders and increased risk of chronic difficulties. New studies have shown promising results by focusing on improving emotional regulation. We lack knowledge about differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress. Children 6 to 12 years admitted to specialist and diagnosed with ADHD will be recruited. ADHD children with and without emotional dysregulation defined as fullfilling the criteria for the diagnosis Disruptive Mood Dysregulation Disorder (DMDD) with regard to differences in symptom patterns, stability of symptoms over time, comorbid disorders, neurocognitive functions, knowledge and regulation of emotions, psychosocial risk factors and reactions to stress..

Detailed description

Children referred to outpatient psychiatric service will be informed about the study and asked to participate. The clinical assessments in the study will be those that are recommended as good clinical practice, so results will be included in the diagnostic work for the patient. The data security will follow the Norwegian rules and be monitored by REC and the Data Inspectorate of the hospital.

Conditions

Interventions

TypeNameDescription
OTHERTreatment as usual for ADHDChildren are given treatment according to diagnostic conclusion and clinical recommendations.

Timeline

Start date
2019-06-01
Primary completion
2021-08-01
Completion
2021-08-01
First posted
2019-05-09
Last updated
2019-05-13

Locations

1 site across 1 country: Norway

Source: ClinicalTrials.gov record NCT03944083. Inclusion in this directory is not an endorsement.